A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The ...

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a ...

Office of the Utah Attorney General and the Utah Department of Commerce’s Division of Consumer Protection are issuing a ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, ...

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a ...

Our previous report on the Chapter 11 case of 23andMe discussed the Sale Order entered by the Bankruptcy Court on June 27, ...

Me’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed nonprofit led by the genetic testing company’s co-founder, Anne Wojcicki, ...

Genetic testing company 23andMe can proceed with a US$305-million sale to the company’s co-founder Anne Wojcicki after a U.S. bankruptcy judge rejected California’s bid to delay the sale while the ...

23andMe ended the quarter with cash and cash equivalents of $127 million, compared with $216 million as of March 31, 2024. Last month, 23andMe completed a 1-for-20 reverse stock split.

23andMe's future is uncertain amid potential acquisition talks. The company has faced a data breach and board resignations. Some have called for users to delete data out of concern policies may ...

23andMe says on its website that any buyer must comply with laws around handling customer data. The company plans to continue selling kits and offering subscriptions.